Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
University of Paris-Sorbonne
París, FranciaPublicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (7)
2024
-
Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies
CardioVascular and Interventional Radiology, Vol. 47, Núm. 3, pp. 310-324
2023
-
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422
2021
-
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
JHEP Reports, Vol. 3, Núm. 3
-
Short-term Safety and Quality of Life Outcomes Following Radioembolization in Primary and Secondary Liver Tumours: a Multi-centre Analysis of 200 Patients in France
CardioVascular and Interventional Radiology, Vol. 44, Núm. 1, pp. 36-49
2020
-
A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL
Digestive and Liver Disease, Vol. 52, Núm. 8, pp. 857-861
-
Milestones in the pathogenesis and management of primary liver cancer
Journal of Hepatology
2016
-
Hepatocellular carcinoma
Nature Reviews Disease Primers, Vol. 2